Multiplex Assays Market (By Product: Consumables, Instruments, Software; By Type: Protein Multiplex Assays, Nucleic Acid Multiplex Assays, Cell-based Multiplex Assays; By Technology: Flow Cytometry, Fluorescence Detection, Luminescence, By Application: Research & Development, Clinical Diagnostics; By End-use: Pharmaceutical & Biotechnology Companies, Hospitals & Diagnostic Laboratories) - Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2024-2033
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology (Premium Insights)
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Multiplex Assays Market
5.1. COVID-19 Landscape: Multiplex Assays Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Multiplex Assays Market, By Product
8.1. Multiplex Assays Market Revenue and Volume, by Product, 2024-2033
8.1.1. Consumables
8.1.1.1. Market Revenue and Volume Forecast (2021-2033)
8.1.2. Instruments
8.1.2.1. Market Revenue and Volume Forecast (2021-2033)
8.1.3. Software
8.1.3.1. Market Revenue and Volume Forecast (2021-2033)
Chapter 9. Global Multiplex Assays Market, By Type
9.1. Multiplex Assays Market Revenue and Volume, by Type, 2024-2033
9.1.1. Protein Multiplex Assays
9.1.1.1. Market Revenue and Volume Forecast (2021-2033)
9.1.2. Nucleic Acid Multiplex Assays
9.1.2.1. Market Revenue and Volume Forecast (2021-2033)
9.1.3. Cell-based Multiplex Assays
9.1.3.1. Market Revenue and Volume Forecast (2021-2033)
Chapter 10. Global Multiplex Assays Market, By Technology
10.1. Multiplex Assays Market Revenue and Volume, by Technology, 2024-2033
10.1.1. Flow Cytometry
10.1.1.1. Market Revenue and Volume Forecast (2021-2033)
10.1.2. Flow Cytometry
10.1.2.1. Market Revenue and Volume Forecast (2021-2033)
10.1.3. Luminescence
10.1.3.1. Market Revenue and Volume Forecast (2021-2033)
10.1.4. Multiplex Real-Time PCR
10.1.4.1. Market Revenue and Volume Forecast (2021-2033)
10.1.5. Other Technologies
10.1.5.1. Market Revenue and Volume Forecast (2021-2033)
Chapter 11. Global Multiplex Assays Market, By End-use
11.1. Multiplex Assays Market Revenue and Volume, by End-use, 2024-2033
11.1.1. Pharmaceutical & Biotechnology Companies
11.1.1.1. Market Revenue and Volume Forecast (2021-2033)
11.1.2. Hospitals & Diagnostic Laboratories
11.1.2.1. Market Revenue and Volume Forecast (2021-2033)
11.1.3. Research & Academic Institutes
11.1.3.1. Market Revenue and Volume Forecast (2021-2033)
11.1.4. Other End-users
11.1.4.1. Market Revenue and Volume Forecast (2021-2033)
Chapter 12. Global Multiplex Assays Market, By Application
12.1. Multiplex Assays Market Revenue and Volume, by Application, 2024-2033
12.1.1. Research & Development
12.1.1.1. Market Revenue and Volume Forecast (2021-2033)
12.1.2. Clinical Diagnostics
12.1.2.1. Market Revenue and Volume Forecast (2021-2033)
Chapter 13. Global Multiplex Assays Market, Regional Estimates and Trend Forecast
13.1. North America
13.1.1. Market Revenue and Volume Forecast, by Product (2021-2033)
13.1.2. Market Revenue and Volume Forecast, by Type (2021-2033)
13.1.3. Market Revenue and Volume Forecast, by Technology (2021-2033)
13.1.4. Market Revenue and Volume Forecast, by End-use (2021-2033)
13.1.5. Market Revenue and Volume Forecast, by Application (2021-2033)
13.1.6. U.S.
13.1.6.1. Market Revenue and Volume Forecast, by Product (2021-2033)
13.1.6.2. Market Revenue and Volume Forecast, by Type (2021-2033)
13.1.6.3. Market Revenue and Volume Forecast, by Technology (2021-2033)
13.1.6.4. Market Revenue and Volume Forecast, by End-use (2021-2033)
13.1.6.5. Market Revenue and Volume Forecast, by Application (2021-2033)
13.1.7. Rest of North America
13.1.7.1. Market Revenue and Volume Forecast, by Product (2021-2033)
13.1.7.2. Market Revenue and Volume Forecast, by Type (2021-2033)
13.1.7.3. Market Revenue and Volume Forecast, by Technology (2021-2033)
13.1.7.4. Market Revenue and Volume Forecast, by End-use (2021-2033)
13.1.7.5. Market Revenue and Volume Forecast, by Application (2021-2033)
13.2. Europe
13.2.1. Market Revenue and Volume Forecast, by Product (2021-2033)
13.2.2. Market Revenue and Volume Forecast, by Type (2021-2033)
13.2.3. Market Revenue and Volume Forecast, by Technology (2021-2033)
13.2.4. Market Revenue and Volume Forecast, by End-use (2021-2033)
13.2.5. Market Revenue and Volume Forecast, by Application (2021-2033)
13.2.6. UK
13.2.6.1. Market Revenue and Volume Forecast, by Product (2021-2033)
13.2.6.2. Market Revenue and Volume Forecast, by Type (2021-2033)
13.2.6.3. Market Revenue and Volume Forecast, by Technology (2021-2033)
13.2.7. Market Revenue and Volume Forecast, by End-use (2021-2033)
13.2.8. Market Revenue and Volume Forecast, by Application (2021-2033)
13.2.9. Germany
13.2.9.1. Market Revenue and Volume Forecast, by Product (2021-2033)
13.2.9.2. Market Revenue and Volume Forecast, by Type (2021-2033)
13.2.9.3. Market Revenue and Volume Forecast, by Technology (2021-2033)
13.2.10. Market Revenue and Volume Forecast, by End-use (2021-2033)
13.2.11. Market Revenue and Volume Forecast, by Application (2021-2033)
13.2.12. France
13.2.12.1. Market Revenue and Volume Forecast, by Product (2021-2033)
13.2.12.2. Market Revenue and Volume Forecast, by Type (2021-2033)
13.2.12.3. Market Revenue and Volume Forecast, by Technology (2021-2033)
13.2.12.4. Market Revenue and Volume Forecast, by End-use (2021-2033)
13.2.13. Market Revenue and Volume Forecast, by Application (2021-2033)
13.2.14. Rest of Europe
13.2.14.1. Market Revenue and Volume Forecast, by Product (2021-2033)
13.2.14.2. Market Revenue and Volume Forecast, by Type (2021-2033)
13.2.14.3. Market Revenue and Volume Forecast, by Technology (2021-2033)
13.2.14.4. Market Revenue and Volume Forecast, by End-use (2021-2033)
13.2.15. Market Revenue and Volume Forecast, by Application (2021-2033)
13.3. APAC
13.3.1. Market Revenue and Volume Forecast, by Product (2021-2033)
13.3.2. Market Revenue and Volume Forecast, by Type (2021-2033)
13.3.3. Market Revenue and Volume Forecast, by Technology (2021-2033)
13.3.4. Market Revenue and Volume Forecast, by End-use (2021-2033)
13.3.5. Market Revenue and Volume Forecast, by Application (2021-2033)
13.3.6. India
13.3.6.1. Market Revenue and Volume Forecast, by Product (2021-2033)
13.3.6.2. Market Revenue and Volume Forecast, by Type (2021-2033)
13.3.6.3. Market Revenue and Volume Forecast, by Technology (2021-2033)
13.3.6.4. Market Revenue and Volume Forecast, by End-use (2021-2033)
13.3.7. Market Revenue and Volume Forecast, by Application (2021-2033)
13.3.8. China
13.3.8.1. Market Revenue and Volume Forecast, by Product (2021-2033)
13.3.8.2. Market Revenue and Volume Forecast, by Type (2021-2033)
13.3.8.3. Market Revenue and Volume Forecast, by Technology (2021-2033)
13.3.8.4. Market Revenue and Volume Forecast, by End-use (2021-2033)
13.3.9. Market Revenue and Volume Forecast, by Application (2021-2033)
13.3.10. Japan
13.3.10.1. Market Revenue and Volume Forecast, by Product (2021-2033)
13.3.10.2. Market Revenue and Volume Forecast, by Type (2021-2033)
13.3.10.3. Market Revenue and Volume Forecast, by Technology (2021-2033)
13.3.10.4. Market Revenue and Volume Forecast, by End-use (2021-2033)
13.3.10.5. Market Revenue and Volume Forecast, by Application (2021-2033)
13.3.11. Rest of APAC
13.3.11.1. Market Revenue and Volume Forecast, by Product (2021-2033)
13.3.11.2. Market Revenue and Volume Forecast, by Type (2021-2033)
13.3.11.3. Market Revenue and Volume Forecast, by Technology (2021-2033)
13.3.11.4. Market Revenue and Volume Forecast, by End-use (2021-2033)
13.3.11.5. Market Revenue and Volume Forecast, by Application (2021-2033)
13.4. MEA
13.4.1. Market Revenue and Volume Forecast, by Product (2021-2033)
13.4.2. Market Revenue and Volume Forecast, by Type (2021-2033)
13.4.3. Market Revenue and Volume Forecast, by Technology (2021-2033)
13.4.4. Market Revenue and Volume Forecast, by End-use (2021-2033)
13.4.5. Market Revenue and Volume Forecast, by Application (2021-2033)
13.4.6. GCC
13.4.6.1. Market Revenue and Volume Forecast, by Product (2021-2033)
13.4.6.2. Market Revenue and Volume Forecast, by Type (2021-2033)
13.4.6.3. Market Revenue and Volume Forecast, by Technology (2021-2033)
13.4.6.4. Market Revenue and Volume Forecast, by End-use (2021-2033)
13.4.7. Market Revenue and Volume Forecast, by Application (2021-2033)
13.4.8. North Africa
13.4.8.1. Market Revenue and Volume Forecast, by Product (2021-2033)
13.4.8.2. Market Revenue and Volume Forecast, by Type (2021-2033)
13.4.8.3. Market Revenue and Volume Forecast, by Technology (2021-2033)
13.4.8.4. Market Revenue and Volume Forecast, by End-use (2021-2033)
13.4.9. Market Revenue and Volume Forecast, by Application (2021-2033)
13.4.10. South Africa
13.4.10.1. Market Revenue and Volume Forecast, by Product (2021-2033)
13.4.10.2. Market Revenue and Volume Forecast, by Type (2021-2033)
13.4.10.3. Market Revenue and Volume Forecast, by Technology (2021-2033)
13.4.10.4. Market Revenue and Volume Forecast, by End-use (2021-2033)
13.4.10.5. Market Revenue and Volume Forecast, by Application (2021-2033)
13.4.11. Rest of MEA
13.4.11.1. Market Revenue and Volume Forecast, by Product (2021-2033)
13.4.11.2. Market Revenue and Volume Forecast, by Type (2021-2033)
13.4.11.3. Market Revenue and Volume Forecast, by Technology (2021-2033)
13.4.11.4. Market Revenue and Volume Forecast, by End-use (2021-2033)
13.4.11.5. Market Revenue and Volume Forecast, by Application (2021-2033)
13.5. Latin America
13.5.1. Market Revenue and Volume Forecast, by Product (2021-2033)
13.5.2. Market Revenue and Volume Forecast, by Type (2021-2033)
13.5.3. Market Revenue and Volume Forecast, by Technology (2021-2033)
13.5.4. Market Revenue and Volume Forecast, by End-use (2021-2033)
13.5.5. Market Revenue and Volume Forecast, by Application (2021-2033)
13.5.6. Brazil
13.5.6.1. Market Revenue and Volume Forecast, by Product (2021-2033)
13.5.6.2. Market Revenue and Volume Forecast, by Type (2021-2033)
13.5.6.3. Market Revenue and Volume Forecast, by Technology (2021-2033)
13.5.6.4. Market Revenue and Volume Forecast, by End-use (2021-2033)
13.5.7. Market Revenue and Volume Forecast, by Application (2021-2033)
13.5.8. Rest of LATAM
13.5.8.1. Market Revenue and Volume Forecast, by Product (2021-2033)
13.5.8.2. Market Revenue and Volume Forecast, by Type (2021-2033)
13.5.8.3. Market Revenue and Volume Forecast, by Technology (2021-2033)
13.5.8.4. Market Revenue and Volume Forecast, by End-use (2021-2033)
13.5.8.5. Market Revenue and Volume Forecast, by Application (2021-2033)
Chapter 14. Company Profiles
14.1. R&D Systems, Inc.
14.1.1. Company Overview
14.1.2. Product Offerings
14.1.3. Financial Performance
14.1.4. Recent Initiatives
14.2. Advanced Cell Diagnostics
14.2.1. Company Overview
14.2.2. Product Offerings
14.2.3. Financial Performance
14.2.4. Recent Initiatives
14.3. Perkin Elmer Inc.
14.3.1. Company Overview
14.3.2. Product Offerings
14.3.3. Financial Performance
14.3.4. Recent Initiatives
14.4. Thermo Fischer Scientific
14.4.1. Company Overview
14.4.2. Product Offerings
14.4.3. Financial Performance
14.4.4. Recent Initiatives
14.5. QIAGEN N.V
14.5.1. Company Overview
14.5.2. Product Offerings
14.5.3. Financial Performance
14.5.4. Recent Initiatives
14.6. Promega Connections
14.6.1. Company Overview
14.6.2. Product Offerings
14.6.3. Financial Performance
14.6.4. Recent Initiatives
14.7. Assay Genie
14.7.1. Company Overview
14.7.2. Product Offerings
14.7.3. Financial Performance
14.7.4. Recent Initiatives
14.8. Merck KGaA
14.8.1. Company Overview
14.8.2. Product Offerings
14.8.3. Financial Performance
14.8.4. Recent Initiatives
14.9. Seegene Inc.
14.9.1. Company Overview
14.9.2. Product Offerings
14.9.3. Financial Performance
14.9.4. Recent Initiatives
14.10. Abcam Plc
14.10.1. Company Overview
14.10.2. Product Offerings
14.10.3. Financial Performance
14.10.4. Recent Initiatives
Chapter 15. Research Methodology
15.1. Primary Research
15.2. Secondary Research
15.3. Assumptions
Chapter 16. Appendix
16.1. About Us
16.2. Glossary of Terms
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client